4-phenylenediamine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Brites, G; Carrascal, MA; Cruz, MT; Moreira, P; Neves, B; Pereira, C; Pereira, M; Resende, R; Santos, AE; Silva, A; Silva, MM | 1 |
| Achouri, Y; Baeck, M; Cheou, P; Cochez, PM; de Heusch, M; Dumoutier, L; Hendrickx, E; Opsomer, R; Pointner, L; Raynaud, P; Renauld, JC; Van Belle, AB; Warnier, G | 1 |
| Abernathy, E; Alt, C; Arora, P; Bloch, KD; Brouckaert, P; Buys, ES; Clerté, M; de Waard, N; Giani, A; Gong, H; Gregory, MS; Hayton, SR; Jones, A; Kang, JH; Ko, YC; Ksander, BR; Lin, CP; Loomis, SJ; Malhotra, R; Nathan, D; Oh, DJ; Pasquale, LR; Ren, R; Rhee, DJ; Scherrer-Crosbie, M; Tainsh, LT; Tainsh, RE; Turcotte, R; Wiggs, JL; Yu, B | 1 |
| Abràmoff, MD; Anderson, MG; Christopher, M; Fingert, JH; Hedberg-Buenz, A; Miller, K; Scheetz, TE; Tandon, A; Zarei, K | 1 |
| Fu, CT; Sretavan, D | 1 |
| Barakat, D; Bethea, JR; Brambilla, R; Dvoriantchikova, G; Ivanov, D; Shestopalov, VI | 1 |
| Auburger, G; Cabin, DE; Gispert-Sanchez, S; Murphy, D; Myers, RR; Nussbaum, RL | 1 |
| Kalish, RS; Wood, JA | 1 |
9 other study(ies) available for 4-phenylenediamine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Calcium Modulation, Anti-Oxidant and Anti-Inflammatory Effect of Skin Allergens Targeting the Nrf2 Signaling Pathway in Alzheimer's Disease Cellular Models.
Topics: Allergens; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Calcium; Caprylates; Cell Line; Disease Models, Animal; Heme Oxygenase-1; Humans; Membrane Proteins; Mice; Microglia; NF-E2-Related Factor 2; Phenylenediamines; Skin | 2020 |
IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.
Topics: Adult; Aged; Animals; Biopsy; Coloring Agents; Cytokines; Dermatitis, Allergic Contact; Disease Models, Animal; Humans; Immunoglobulin E; Inflammation; Interleukin-22; Interleukins; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Phenylenediamines; Receptors, Interleukin; Skin | 2019 |
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Glaucoma, Open-Angle; Guanylate Cyclase; Immunohistochemistry; Intraocular Pressure; Mice; Mice, Knockout; Mice, Mutant Strains; Ophthalmoscopy; Optic Nerve; Phenylenediamines; Receptors, Cytoplasmic and Nuclear; Retinal Neurons; Soluble Guanylyl Cyclase; Tomography, Optical Coherence | 2013 |
Automated Axon Counting in Rodent Optic Nerve Sections with AxonJ.
Topics: Algorithms; Animals; Axons; Cell Count; Disease Models, Animal; Glaucoma; Humans; Mice; Optic Nerve; Phenylenediamines; Staining and Labeling | 2016 |
Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.
Topics: Animals; Axons; Cell Survival; Coloring Agents; Disease Models, Animal; Ephrin-B2; Ephrin-B3; Glaucoma; Intraocular Pressure; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Degeneration; Ocular Hypertension; Optic Nerve Diseases; Organ Culture Techniques; Phenylenediamines; Recombinant Fusion Proteins; Retinal Ganglion Cells; Signal Transduction; Up-Regulation | 2012 |
Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Topics: Analysis of Variance; Animals; Astrocytes; Cell Count; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Glial Fibrillary Acidic Protein; Membrane Glycoproteins; Mice; Mice, Transgenic; Myelin-Oligodendrocyte Glycoprotein; NADPH Oxidase 2; NADPH Oxidases; Neutrophil Infiltration; NF-kappa B; Optic Nerve; Optic Nerve Diseases; Oxidative Stress; Peptide Fragments; Phenylenediamines; Phosphopyruvate Hydratase; Retinal Ganglion Cells | 2012 |
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Topics: Age Factors; Alanine; alpha-Synuclein; Animals; Behavior, Animal; Blotting, Western; Disease Models, Animal; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Motor Activity; Mutation; Nerve Tissue Proteins; Parkinson Disease; Phenylenediamines; RNA; Sciatic Nerve; Spinal Cord; Synucleins; Threonine; Wallerian Degeneration | 2005 |
Sensitization of mice to paraphenylenediamine and structurally-related compounds: adjuvant effects of vitamin A supplementation.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Animals; Cell Division; Coloring Agents; Dermatitis, Allergic Contact; Disease Models, Animal; Ear, External; Female; Food, Fortified; Hydroquinones; Immunization; Injections, Intraperitoneal; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred Strains; Phenylenediamines; Resorcinols; Spleen; Vitamin A | 1995 |